Upacicalcet sodium is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients. It is a salt-form compound containing a sulfonate group and an amino acid moiety, designed for intravenous administration in dialysis patients with secondary hyperparathyroidism.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2052969-18-1
Amifostine
cytoprotective adjuvant for chemoradiotherapy
Parthenolide
active pharmaceutical ingredient
Oxibendazole
Active pharmaceutical ingredient
(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-amino-3-methylbutanamide
antibody-drug conjugate payload
sodium 3-[[(2S)-2-amino-2-carboxyethyl]carbamoylamino]-5-chloro-4-methylbenzenesulfonate
KUQQRUUFBPFDOW-QRPNPIFTSA-M
CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])NC(=O)NC[C@@H](C(=O)O)N.[Na+]